Literature DB >> 10348475

Dystonia as a presenting feature of the 3243 mitochondrial DNA mutation.

L Sudarsky1, G M Plotkin, E L Logigian, D R Johns.   

Abstract

A variety of neurologic phenotypes have been described in patients with mitochondrial disorders. We report a 32-year-old man in whom dystonia was the salient and presenting feature of a mitochondrial DNA mutation. He presented at age 23 with writer's cramp and progressed over 5 years to exhibit dystonia in facial muscles and lower limbs. He also has exercise intolerance, mild, bilateral ptosis, proximal muscle weakness, and sensorineural hearing loss. Molecular genetic analysis of blood, urine, and muscle biopsy demonstrated the presence of a heteroplasmic point mutation at nucleotide position 3243. The 3243 mtDNA mutation has pleomorphic manifestations, and dystonia should be added to the list of associated clinical features.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348475     DOI: 10.1002/1531-8257(199905)14:3<488::aid-mds1017>3.0.co;2-4

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  8 in total

1.  A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia.

Authors:  David K Simon; Jennifer Friedman; Xandra O Breakefield; Joseph Jankovic; Mitchell F Brin; John Provias; Susan B Bressman; Michael E Charness; Daniel Tarsy; Donald R Johns; Mark A Tarnopolsky
Journal:  Neurogenetics       Date:  2003-05-17       Impact factor: 2.660

Review 2.  Experimental therapeutics for dystonia.

Authors:  H A Jinnah; Ellen J Hess
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

3.  Familial Pernicious Chronic Intestinal Pseudo-obstruction with a Mitochondrial DNA A3243G Mutation.

Authors:  Junichiro Suzuki; Mai Iwata; Hideyuki Moriyoshi; Suguru Nishida; Takeshi Yasuda; Yasuhiro Ito
Journal:  Intern Med       Date:  2017-05-01       Impact factor: 1.271

4.  Chorea-ballism as a dominant clinical manifestation in heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation in mitochondrial genome: a case report.

Authors:  Durjoy Lahiri; Vishal Madhukar Sawale; Subhadeep Banerjee; Souvik Dubey; Biman Kanti Roy; Shyamal Kumar Das
Journal:  J Med Case Rep       Date:  2019-03-06

Review 5.  Genetic Dystonia-ataxia Syndromes: Clinical Spectrum, Diagnostic Approach, and Treatment Options.

Authors:  Malco Rossi; Bettina Balint; Patricio Millar Vernetti; Kailash P Bhatia; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2018-07-03

6.  Multiple neurologic, psychiatric, and endocrine complaints in a young woman: a case discussion and review of the clinical features and management of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke.

Authors:  Chaya G Bhuvaneswar; Jared L Goetz; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

7.  Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases.

Authors:  Chiara Ticci; Daniele Orsucci; Anna Ardissone; Luca Bello; Enrico Bertini; Irene Bonato; Claudio Bruno; Valerio Carelli; Daria Diodato; Stefano Doccini; Maria Alice Donati; Claudia Dosi; Massimiliano Filosto; Chiara Fiorillo; Chiara La Morgia; Costanza Lamperti; Silvia Marchet; Diego Martinelli; Carlo Minetti; Maurizio Moggio; Tiziana Enrica Mongini; Vincenzo Montano; Isabella Moroni; Olimpia Musumeci; Elia Pancheri; Elena Pegoraro; Guido Primiano; Elena Procopio; Anna Rubegni; Roberta Scalise; Monica Sciacco; Serenella Servidei; Gabriele Siciliano; Costanza Simoncini; Deborah Tolomeo; Paola Tonin; Antonio Toscano; Flavia Tubili; Michelangelo Mancuso; Roberta Battini; Filippo Maria Santorelli
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

Review 8.  Movement disorders and inborn errors of metabolism in adults: a diagnostic approach.

Authors:  F Sedel; J-M Saudubray; E Roze; Y Agid; M Vidailhet
Journal:  J Inherit Metab Dis       Date:  2008-05-30       Impact factor: 4.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.